Revenue: The sum of all revenue fields included for a company's operating activities.
Boston Scientific Corporation (BSX) had Revenue of $5.06B for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$5.06B |
$797.00M |
|
$1.64B |
|
$3.42B |
|
$4.24B |
|
$819.00M |
|
$123.00M |
|
$941.00M |
|
$941.00M |
|
$795.00M |
|
$795.00M |
|
$795.00M |
|
$795.00M |
|
$819.00M |
|
$1.20B |
|
1.48B |
|
1.49B |
|
$0.54 |
|
$0.53 |
|
| Balance Sheet Financials | |
$7.12B |
|
$3.46B |
|
$34.44B |
|
$41.56B |
|
$5.19B |
|
$11.11B |
|
$13.72B |
|
$18.91B |
|
$22.65B |
|
$-2.68B |
|
$22.65B |
|
1.48B |
|
| Cash Flow Statement Financials | |
$1.83B |
|
$-1.63B |
|
$-107.00M |
|
$606.00M |
|
$741.00M |
|
$135.00M |
|
$149.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.37 |
|
-- |
|
-- |
|
0.33 |
|
0.51 |
|
67.65% |
|
16.18% |
|
16.18% |
|
-- |
|
18.59% |
|
15.75% |
|
$1.48B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.57 |
|
1.80 |
|
50.06 |
|
3.51% |
|
-29.63% |
|
1.91% |
|
2.35% |
|
$15.30 |
|
$0.99 |
|
$1.22 |
|